Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes

por Ito, Rika, Fukui, Tomoyasu, Hayashi, Toshiyuki, Osamura, Anna, Ohara, Makoto, Hara, Noriko, Higuchi, Akiko, Yamamoto, Takeshi, Hirano, Tsutomu
Publicado 2015

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitag...

por Hayashi, Toshiyuki, Fukui, Tomoyasu, Nakanishi, Noriko, Yamamoto, Saki, Tomoyasu, Masako, Osamura, Anna, Ohara, Makoto, Yamamoto, Takeshi, Ito, Yasuki, Hirano, Tsutomu
Publicado 2017

Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: compar...

por Hayashi, Toshiyuki, Fukui, Tomoyasu, Nakanishi, Noriko, Yamamoto, Saki, Tomoyasu, Masako, Osamura, Anna, Ohara, Makoto, Yamamoto, Takeshi, Ito, Yasuki, Hirano, Tsutomu
Publicado 2017